Carisma Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Carisma Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Carisma Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Carisma Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.5k | 16k | 0.27 |
| 2024-12-31 | $9.0k | 21k | 0.42 |
| 2024-06-30 | $354k | 233k | 1.52 |
| 2023-12-31 | $31k | 11k | 2.93 |
| 2023-09-30 | $54k | 13k | 4.23 |
| 2023-06-30 | $243k | 28k | 8.77 |